Non-epileptic myoclonus in Angelman syndrome

No direct evidence for optimal treatment of non-epileptic myoclonus in Angelman syndrome was identified. Observational reports suggest potential benefits from perampanel, reserpine, clonazepam, and cannabidiol, yet further research is necessary to validate these findings.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-06
DOI
https://doi.org/10.5281/zenodo.24021276
Primary Topic
Epilepsy research and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Non-epileptic myoclonus in Angelman syndrome

Tripdatabase
Zenodo (CERN European Organization for Nuclear Research)
Epilepsy research and treatment
article

Non-epileptic myoclonus in Angelman syndrome

Tripdatabase
article en

Abstract

No direct evidence for optimal treatment of non-epileptic myoclonus in Angelman syndrome was identified. Observational reports suggest potential benefits from perampanel, reserpine, clonazepam, and cannabidiol, yet further research is necessary to validate these findings.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 15%
Epilepsy research and treatment
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Non-epileptic myoclonus in Angelman syndrome — Tripdatabase · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS